Skip to main content
Premium Trial:

Request an Annual Quote

Unigen to Use Omics Tools to Discover Potential Therapeutics in Atlantic Ocean Microbes

NEW YORK (GenomeWeb News) - Unigen Pharmaceuticals and the University of Prince Edward Island will work together to study marine microorganisms from the Atlantic Ocean with the hopes of making discoveries that may lead to new therapeutics and commercial products, Unigen said late last week.
The marine collection research will be led by Russell Kerr, Canada Research Chair in Marine Natural Products at UPEI, who has been collecting samples from tropical Atlantic waters for two decades.
Unigen will extract the microbes from the samples and fractionate them using a high-throughput purification system, and will test these fractions on "biochemical, genomic, proteomic, in vitro, in vivo, and ex vivo models," the company said.
The company said active ingredients will be "separated and identified as leads for the development of pharmaceutical, nutraceutical, cosmoceutical, and functional food products."

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.